Pirtobrutinib monotherapy in patients with relapsed/refractory B-cell malignancies intolerant to prior covalent BTK inhibitor

Munir, T; Shah, NN; Wang, M; Brown, JR; Patel, K; Woyach, J; Wierda, WG; Ujjani, CS; Eyre, TA; Zinzani, PL; Alencar, AJ; Gastinne, T; Ghia, P; Lamanna, N; Hoffmann, MS; Patel, MR; Flinn, I; Gerson, JN; Ma, S; Coombs, CC; Cheah, CY; Lech-Maranda, E; Fakhri, B; Kim, WS; Barve, MA; Cohen, JB; Jurczak, W; Thompson, MC; Roeker, LE; Bao, K; Cangemi, NA; Kherani, JF; Walgren, RA; Han, H; Ruppert, AS; Mato, AR

BRITISH JOURNAL OF HAEMATOLOGY, 2023; 201 (): 13